Exosome-mediated delivery of functionally active miRNA-375-3p mimic regulate epithelial mesenchymal transition (EMT) of colon cancer cells
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Exosome-mediated delivery of functionally active miRNA-375-3p mimic regulate epithelial mesenchymal transition (EMT) of colon cancer cells
Authors
Keywords
Epithelial mesenchymal transition, EMT, Exosomes, Gastrointestinal cancer, Cancer stem cell, miR-375
Journal
LIFE SCIENCES
Volume 269, Issue -, Pages 119035
Publisher
Elsevier BV
Online
2021-01-14
DOI
10.1016/j.lfs.2021.119035
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MicroRNA‑375 prevents TGF‑β‑dependent transdifferentiation of lung fibroblasts via the MAP2K6/P38 pathway
- (2020) Xinghua Zhang et al. Molecular Medicine Reports
- Epithelial-To-Mesenchymal Transition Markers and CD44 Isoforms Are Differently Expressed in 2D and 3D Cell Cultures of Prostate Cancer Cells
- (2019) Fabrizio Fontana et al. Cells
- Tissue-specific transcription reprogramming promotes liver metastasis of colorectal cancer
- (2019) Shuaishuai Teng et al. CELL RESEARCH
- TGFβ-induced metabolic reprogramming during epithelial-to-mesenchymal transition in cancer
- (2019) Wan Hua et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Exosomal cargo-loading and synthetic exosome-mimics as potential therapeutic tools
- (2018) Song-pei Li et al. ACTA PHARMACOLOGICA SINICA
- Epithelial Mesenchymal Transition in Tumor Metastasis
- (2018) Vivek Mittal Annual Review of Pathology-Mechanisms of Disease
- Epithelial–mesenchymal-transition-inducing transcription factors: new targets for tackling chemoresistance in cancer?
- (2018) Jente van Staalduinen et al. ONCOGENE
- Magnesium isoglycyrrhizinate ameliorates high fructose-induced liver fibrosis in rat by increasing miR-375-3p to suppress JAK2/STAT3 pathway and TGF-β1/Smad signaling
- (2018) Yan-zi Yang et al. ACTA PHARMACOLOGICA SINICA
- Epithelial-mesenchymal transition (EMT): A biological process in the development, stem cell differentiation, and tumorigenesis
- (2017) Tong Chen et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Cancer stem cells: The root of tumor recurrence and metastases
- (2017) Claudia Peitzsch et al. SEMINARS IN CANCER BIOLOGY
- Concise Review: MSC-Derived Exosomes for Cell-Free Therapy
- (2017) Donald G. Phinney et al. STEM CELLS
- Nanoparticle delivery of Wnt-1 siRNA enhances photodynamic therapy by inhibiting epithelial–mesenchymal transition for oral cancer
- (2017) Chuan Ma et al. Biomaterials Science
- Exosome-Based Cancer Therapy: Implication for Targeting Cancer Stem Cells
- (2017) Jinheng Wang et al. Frontiers in Pharmacology
- Synergistic effects of CD44 and TGF-β1 through AKT/GSK-3β/β-catenin signaling during epithelial-mesenchymal transition in liver cancer cells
- (2016) Na Ri Park et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Bovine milk-derived exosomes for drug delivery
- (2016) Radha Munagala et al. CANCER LETTERS
- Epithelial–mesenchymal transition (EMT) and metastasis: yes, no, maybe?
- (2016) Maren Diepenbruck et al. CURRENT OPINION IN CELL BIOLOGY
- Exploitation of Exosomes as Nanocarriers for Gene-, Chemo-, and Immune-Therapy of Cancer
- (2016) Akhil Srivastava et al. Journal of Biomedical Nanotechnology
- Epithelial-mesenchymal transition in tumor metastasis
- (2016) Kay T. Yeung et al. Molecular Oncology
- A ZEB1-miR-375-YAP1 pathway regulates epithelial plasticity in prostate cancer
- (2016) L A Selth et al. ONCOGENE
- miR-375 inhibits the invasion and metastasis of colorectal cancer via targeting SP1 and regulating EMT-associated genes
- (2016) FENGYUN CUI et al. ONCOLOGY REPORTS
- p38 MAPK mediates epithelial-mesenchymal transition by regulating p38IP and Snail in head and neck squamous cell carcinoma
- (2016) Yuan Lin et al. ORAL ONCOLOGY
- In vivo delivery of miRNAs for cancer therapy: Challenges and strategies
- (2015) Yunching Chen et al. ADVANCED DRUG DELIVERY REVIEWS
- ZEB1: At the crossroads of epithelial-mesenchymal transition, metastasis and therapy resistance
- (2015) Peijing Zhang et al. CELL CYCLE
- Epigenetic deregulated miR-375 contributes to the constitutive activation of JAK2/STAT signaling in myeloproliferative neoplasm
- (2015) Li-hui Yin et al. LEUKEMIA RESEARCH
- MicroRNA-9 promotes tumor metastasis via repressing E-cadherin in esophageal squamous cell carcinoma
- (2015) Ye Song et al. Oncotarget
- Examination of the specificity of tumor cell derived exosomes with tumor cells in vitro
- (2014) Tyson J. Smyth et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- A MDM2-dependent positive-feedback loop is involved in inhibition of miR-375 and miR-106b induced byHelicobacter pylorilipopolysaccharide
- (2014) Feng Ye et al. INTERNATIONAL JOURNAL OF CANCER
- MicroRNA-34a functions as an anti-metastatic microRNA and suppresses angiogenesis in bladder cancer by directly targeting CD44
- (2014) Gan Yu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- miR-106b modulates cancer stem cell characteristics through TGF-β/Smad signaling in CD44-positive gastric cancer cells
- (2014) Dayeon Yu et al. LABORATORY INVESTIGATION
- Prognostic significance of Zinc finger E-box binding homeobox 1 (ZEB1) expression in cancer cells and cancer-associated fibroblasts in pancreatic head cancer
- (2014) Peter Bronsert et al. SURGERY
- MiR-203 is downregulated in laryngeal squamous cell carcinoma and can suppress proliferation and induce apoptosis of tumours
- (2014) Linli Tian et al. TUMOR BIOLOGY
- SHOX2 Is a Direct miR-375 Target and a Novel Epithelial-to-Mesenchymal Transition Inducer in Breast Cancer Cells
- (2014) Sungguan Hong et al. NEOPLASIA
- A systematic evaluation of miRNA:mRNA interactions involved in the migration and invasion of breast cancer cells
- (2013) Daya Luo et al. Journal of Translational Medicine
- MicroRNA-375 Is Downregulated in Pancreatic Cancer and Inhibits Cell Proliferation In Vitro
- (2013) Jian Zhou et al. ONCOLOGY RESEARCH
- Zinc finger E-box binding homeobox 1 promotes invasion and bone metastasis of small cell lung cancerin vitroandin vivo
- (2012) Yi Liu et al. CANCER SCIENCE
- Involvement of ZEB1 and E-cadherin in the invasion of lung squamous cell carcinoma
- (2012) Jiaxing Zhang et al. MOLECULAR BIOLOGY REPORTS
- The epithelial–mesenchymal transition under control: Global programs to regulate epithelial plasticity
- (2012) M. Angela Nieto et al. SEMINARS IN CANCER BIOLOGY
- High expression of ZEB1 correlates with liver metastasis and poor prognosis in colorectal cancer
- (2012) GUANG-JUN ZHANG et al. Oncology Letters
- Clinicopathological Significance of ZEB1 Protein in Patients with Hepatocellular Carcinoma
- (2011) Yan-Ming Zhou et al. ANNALS OF SURGICAL ONCOLOGY
- Clinical significance of zinc finger E-box binding homeobox 1 (ZEB1) in human gastric cancer
- (2011) Yoshinaga Okugawa et al. JOURNAL OF SURGICAL ONCOLOGY
- Overexpression of ZEB1 relates to metastasis and invasion in osteosarcoma
- (2011) Aidong Shen et al. JOURNAL OF SURGICAL ONCOLOGY
- MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo
- (2011) X-X He et al. ONCOGENE
- MicroRNA-375 Is Downregulated in Gastric Carcinomas and Regulates Cell Survival by Targeting PDK1 and 14-3-3
- (2010) Y. Tsukamoto et al. CANCER RESEARCH
- Function of microRNA-375 and microRNA-124a in pancreas and brain
- (2009) Nadine N. Baroukh et al. FEBS Journal
- The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs
- (2009) Ulrich Wellner et al. NATURE CELL BIOLOGY
- Loss of E-Cadherin Promotes Metastasis via Multiple Downstream Transcriptional Pathways
- (2008) T. T. Onder et al. CANCER RESEARCH
- The Transcriptional Repressor ZEB1 Promotes Metastasis and Loss of Cell Polarity in Cancer
- (2008) S. Spaderna et al. CANCER RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More